In this article, we are going to take a look at where Arcus Biosciences, Inc. (NYSE:RCUS) stands against other stocks with at least $10 million in insider spending recently. Since Donald Trump ...
HAYWARD, Calif., February 18, 2025--(BUSINESS WIRE)--Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback